U Seligsohn

Author PubWeight™ 127.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999 5.34
2 Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med 1996 2.38
3 Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 1998 2.34
4 Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984 2.26
5 False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost 2009 2.14
6 One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995 2.05
7 Inherited thrombophilia: Part 1. Thromb Haemost 1996 2.00
8 Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991 1.56
9 Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) 1999 1.54
10 Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. Blood 1991 1.47
11 Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost 2011 1.46
12 Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet 1999 1.38
13 Inherited thrombophilia: Part 2. Thromb Haemost 1996 1.34
14 Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost 1978 1.30
15 Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991 1.28
16 Inherited platelet disorders. Haemophilia 2012 1.27
17 A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemost 1984 1.17
18 Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995 1.15
19 Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med 1970 1.14
20 Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004 1.13
21 Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 1997 1.12
22 The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci U S A 1991 1.12
23 Risk factors associated with postpartum ovarian vein thrombosis. Thromb Haemost 1999 1.11
24 Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood 1979 1.07
25 The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 2001 1.06
26 Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res 1987 1.06
27 Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds. J Lab Clin Med 1985 1.04
28 Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest 1979 1.04
29 Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel. Clin Sci 1971 1.03
30 The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood 1997 1.03
31 Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999 1.01
32 Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol 1977 1.00
33 Combined factor V and factor VIII deficiency among non-Ashkenazi Jews. N Engl J Med 1982 1.00
34 Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost 1987 0.97
35 Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction. Br Heart J 1990 0.97
36 High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood 1978 0.96
37 Mendelian diseases among Roman Jews: implications for the origins of disease alleles. J Clin Endocrinol Metab 1999 0.95
38 Rare bleeding disorders. Haemophilia 2006 0.95
39 Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases. Thromb Diath Haemorrh 1975 0.95
40 Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 2003 0.94
41 Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis. Blood 1987 0.94
42 Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping. J Clin Invest 1997 0.94
43 Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 1999 0.94
44 ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. Blood 1999 0.93
45 Prenatal diagnosis of Glanzmann's thrombasthenia. Lancet 1986 0.93
46 A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997 0.93
47 Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost 2014 0.93
48 Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: comparison of techniques for carrier detection. Br J Haematol 1986 0.92
49 Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis 1992 0.92
50 Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. J Lab Clin Med 1986 0.92
51 Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 2001 0.91
52 Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17. Br J Haematol 1998 0.91
53 Glanzmann thrombasthenia: new insights from an historical perspective. Semin Hematol 1994 0.90
54 A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998 0.89
55 ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost 1996 0.89
56 Combined factor-V and factor-VIII deficiency: report of four cases. Br J Haematol 1969 0.88
57 Association between hyperflexibility of the thumb and an unexplained bleeding tendency: is it a rule of thumb? Br J Haematol 1998 0.87
58 Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia. J Am Coll Cardiol 1990 0.87
59 Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanzmann's thrombasthenia. Br J Haematol 1975 0.87
60 Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis. Circulation 2002 0.86
61 [Massive sublingual hemorrhage due to coumadin causing suffocation]. Harefuah 1970 0.86
62 A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia. J Thromb Haemost 2005 0.86
63 Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1989 0.86
64 Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thromb Haemost 1996 0.86
65 Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 1998 0.86
66 A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation. J Thromb Haemost 2004 0.86
67 Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants. Br J Haematol 1990 0.85
68 Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII. Thromb Res 1978 0.85
69 Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem 2001 0.85
70 Could the 185delAG BRCA1 mutation be an ancient Jewish mutation? Eur J Hum Genet 1998 0.85
71 Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999 0.84
72 Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism. Hematol J 2001 0.84
73 Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye (Lond) 2001 0.84
74 Disseminated intravascular coagulation in experimental heatstroke. Thromb Diath Haemorrh 1971 0.84
75 High prevalence and impact of subnormal serum vitamin B12 levels in Israeli elders admitted to a geriatric hospital. J Nutr Health Aging 2001 0.84
76 Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI. J Thromb Haemost 2006 0.83
77 Bleeding predictors in factor-XI-deficient patients. Blood Coagul Fibrinolysis 1997 0.83
78 Structural integrity of the glycoprotein IIb and IIIa genes in Glanzmann thrombasthenia patients from Israel. Blood 1988 0.83
79 Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood or urine samples. Thromb Haemost 1991 0.83
80 Trp207Gly in platelet glycoprotein Ibalpha is a novel mutation that disrupts the connection between the leucine-rich repeat domain and the disulfide loop structure and causes Bernard-Soulier syndrome. J Thromb Haemost 2006 0.83
81 Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C. Blood 1999 0.83
82 Ilio-psoas hematoma--its detection, and treatment with special reference to hemophilia. Arch Orthop Trauma Surg 1982 0.82
83 von Willebrand factor multimer patterns in pregnancy-induced hypertension. Thromb Haemost 1989 0.82
84 A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004 0.82
85 New observations on factor XI deficiency. Haemophilia 2004 0.81
86 Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families. Thromb Haemost 1997 0.81
87 Sequestration studies with chromium-51 labeled red cells as criteria for splenectomy. Isr J Med Sci 1968 0.81
88 Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia. Blood 2001 0.81
89 Dubin-Johnson syndrome in Israel. II. Association with factor-VII deficiency. Q J Med 1970 0.80
90 Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb. Blood Coagul Fibrinolysis 1998 0.80
91 Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia. Arterioscler Thromb Vasc Biol 2000 0.80
92 Factor XI deficiency: detection and management during urological surgery. J Urol 1978 0.80
93 Fibrinogen synthesis in adrenalectomized rabbits. Proc Soc Exp Biol Med 1973 0.80
94 Possible role of fibrinogen in the aggregation of white blood cells. Thromb Haemost 1987 0.79
95 Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus. J Clin Endocrinol Metab 1988 0.79
96 Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII. Blood 1978 0.79
97 An αIIb mutation in patients with Glanzmann thrombasthenia located in the N-terminus of blade 1 of the β-propeller (Asn2Asp) disrupts a calcium binding site in blade 6. J Thromb Haemost 2011 0.79
98 A relatively high frequency of severe (type III) von Willebrand's disease in Israel. Br J Haematol 1986 0.79
99 The inheritance of Dubin-Johnson syndrome. Isr J Med Sci 1974 0.78
100 [Massive bleeding due to primary fibrinolysis following rhinoplasty]. Harefuah 1972 0.78
101 Effect of phenobarbital on liver functions in patients with Dubin-Johnson syndrome. Gastroenterology 1974 0.78
102 Decreased factor VIII clotting antigen levels in the combined factor V and VIII deficiency. Thromb Res 1984 0.78
103 Association of the hemophilia A carrier state and hemorrhagic thrombocytopathy with dilatation of the platelet membrane complex. Acta Haematol 1984 0.78
104 Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation. J Thromb Haemost 2004 0.78
105 Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder. Blood 1997 0.78
106 Severe hereditary deficiency of factor VII during pregnancy. Evidence for the absence of transplacental diffusion of factor VII. Thromb Diath Haemorrh 1970 0.77
107 Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene. Blood 1995 0.77
108 Extra-adrenal effect of ACTH on fibrinogen synthesis. Am J Physiol 1973 0.77
109 Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients. J Thromb Haemost 2006 0.77
110 The human platelet alphaIIb gene is not closely linked to its integrin partner beta3. Blood 1999 0.77
111 Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Blood 1996 0.77
112 Clinical bleeding due to diclofenac (Voltaren) Arthritis Rheum 1982 0.77
113 The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost 1989 0.77
114 Hepatic computerized tomography in the Dubin-Johnson syndrome: increased liver density as a diagnostic aid. Comput Radiol 1986 0.77
115 Mutations in the alphaIIb and beta3 genes that cause Glanzmann thrombasthenia can be distinguished by a simple procedure using transformed B-lymphocytes. Thromb Haemost 1998 0.77
116 Dubin-Johnson Syndrome. Abnormal excretion of the isomers of urinary coproporphyrin by clinically unaffected family members. Isr J Med Sci 1974 0.77
117 Coexistence of factor XI (plasma thromboplastin antecedent) deficiency and Gaucher's disease. Isr J Med Sci 1976 0.77
118 Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews. J Thromb Haemost 2013 0.77
119 Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI. J Thromb Haemost 2009 0.77
120 Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazic Jews and the value of activated partial thromboplastin time in its detection. Isr J Med Sci 1981 0.77
121 Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma. Haemophilia 2008 0.77
122 Hemophilia and other clotting disorders. Isr J Med Sci 1974 0.77
123 The inheritance of type I and type III von Willebrand's disease in Israel: linkage analysis, carrier detection and prenatal diagnosis using three intragenic restriction fragment length polymorphisms. Blood Coagul Fibrinolysis 1992 0.76
124 The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements. Clin Pharmacol Ther 1992 0.76
125 Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia. Isr J Med Sci 1990 0.76
126 Multiple myeloma: early vertebral involvement assessed by computerised tomography. Skeletal Radiol 1984 0.76
127 Angio-immunoblastic lymphadenopathy: a case with a 17-year follow-up. Postgrad Med J 1982 0.75
128 The Dubin Johnson syndrome and pregnancy. Acta Hepatogastroenterol (Stuttg) 1977 0.75
129 [The heterogeneity of hereditary disorders of blood coagulation]. Harefuah 1974 0.75
130 ADP-coupled integrin regulation by the extracellular redox system. Pathophysiol Haemost Thromb 2006 0.75
131 Purpura fulminans induced by disseminated intravascular coagulation following infection in 2 unrelated children with double heterozygosity for factor V Leiden and protein S deficiency. Thromb Haemost 1997 0.75
132 Lysine binding to activated human platelets and its similarity to fibrinogen binding. Biochim Biophys Acta 1985 0.75
133 Factor VIII gene rearrangement in hemophilia A carrier detection: a word of caution. Blood 1994 0.75
134 The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques. J Thromb Haemost 2004 0.75
135 Cold-promoted activation of factor VII: is It a problem under blood bank conditions? Haemostasis 1983 0.75
136 [Primary hypercoagulable states]. Harefuah 1987 0.75
137 Parotid gland hemorrhage as a complication of coumarin compound ingestion. Arch Otorhinolaryngol 1985 0.75
138 Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families. J Thromb Haemost 2004 0.75
139 Chronic monocytic leukemia: a case with an eight-year survival. Isr J Med Sci 1968 0.75
140 Haemophiliac hands--a three year follow-up study. Hand 1982 0.75
141 The effect of leukocytic extract on fibrinogen synthesis in rabbits. Thromb Res 1975 0.75
142 Molecular characterization of four novel mutations causing factor VII deficiency. Hematol J 2000 0.75
143 Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families. Thromb Haemost 1992 0.75
144 Effect of corticosteroids upon fibrinogen metabolism in rabbits. Thromb Diath Haemorrh 1973 0.75
145 [Resistance to activated protein C--a novel cause of thrombophilia]. Harefuah 1995 0.75
146 Hereditary deficiency of blood clotting factor VII and Dubin-Johnson syndrome in an Israeli family. Isr J Med Sci 1970 0.75
147 Detection of Haemophilia A carriers by replicate factor VIII activity and factor VIII antigenicity determinations. Br J Haematol 1979 0.75
148 Delayed incorporation of (75Se)selenomethionine into fibrinogen: its effect upon kinetic studies of fibrinogen with (75Se)selenomethionine in rabbits. Br J Haematol 1974 0.75
149 [Ambulatory oral surgery in hemophiliacs]. Harefuah 1980 0.75
150 Unusual course of infectious mononucleosis. JAMA 1967 0.75
151 [International postgraduate training program in medicine: survey of 13 training courses, 1988-1994]. Harefuah 1995 0.75
152 Purpura fulminans in an adult. Isr J Med Sci 1986 0.75
153 Combined factors V and VIII deficiency--the solution. Haemophilia 1998 0.75
154 Hereditary factor XIII deficiency: report of four families and definition of the carrier state. Br J Haematol 1984 0.75
155 Prenatal diagnosis of hereditary protein C deficiency. N Engl J Med 1985 0.75
156 Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor. Br J Haematol 1997 0.75
157 Effects of prolonged administration of high molecular levan on hematological parameters in rabbits. Biochem Exp Biol 1977 0.75
158 Quantitation by flow cytometry of anthracycline drug uptake by peripheral blood and bone marrow cells in human leukemias. Exp Hematol 1986 0.75
159 Gilbert syndrome and factor-VII deficiency. Lancet 1970 0.75
160 [Late onset of hemorrhagic disease of the newborn]. Harefuah 1977 0.75
161 A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state. J Thromb Haemost 2012 0.75
162 Thrombasthenia in Iraqi Jews. Isr J Med Sci 1974 0.75
163 A 14-bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Hum Mutat 1996 0.75
164 Hereditary protein C deficiency during pregnancy. Am J Obstet Gynecol 1987 0.75
165 Multiple myeloma with terminal erythroleukemia. Acta Haematol 1976 0.75
166 Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2004 0.75
167 A proposed system of classification of hemophilia centers for the World Federation of Hemophilia (W.F.H.). Scand J Haematol Suppl 1984 0.75
168 Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions. Transfusion 1984 0.75
169 Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews. Thromb Haemost 1996 0.75
170 The activated partial thromboplastin time and factor XI deficiency. Ann Intern Med 1986 0.75
171 Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results. J Endovasc Ther 2000 0.75
172 Patterns of incorporation of 75 Se-methionine into fibrinogen and other plasma proteins in rabbits stimulated by different test conditions. Thromb Diath Haemorrh 1973 0.75